First Dutch Innovations has appointed Anita Spooren and Robert van den Berg as Managing Directors of Triskelion.
Anita Spooren and Robert van den Berg already were responsible for managing the daily business of Triskelion, after the sudden death of Triskelion’s previous CEO Hans van Veen earlier this year. They both have been working in several management roles within Triskelion and her predecessor TNO, and are well acquainted with the Triskelion business. As Managing Directors, they have a shared responsibility. Robert van den Berg will mainly focus on business, whereas Anita Spooren’s main focus will be on the organization.
With this new management team, First Dutch Innovations and Triskelion have full confidence to reach the goals set for the next years.
Triskelion is proud to announce the development of a unique TrustGel™ method for the animal-species authentication of gelatin.
Click here to learn more about the breakthrough quantitative LC-MS method for the species-specific determination of gelatin.
Or contact us directly for any further questions at TrustGel@triskelion.nl or +31 888 66 1776.
23 April 1964 – 22 July 2017
Hans van Veen, CEO of Triskelion and member of the First Dutch Innovations (FDI) management team, has died at the age of 53.
He inspired many with his energetic and professional style of management. In Hans we lose not only a valued and sincere director but also a man whose attitude was so unconventionally optimistic.
Hans leaves behind a wife and two sons.
You can leave a message in the condoleance register.
On 7 September 2017 a memorial service will be held for Hans. If you wish to receive an invitation for this, please mail email@example.com.
Last week the 6th edition of the TIM (TNO gastroIntestinal Model) User Group meeting took place in Amsterdam. The 2-day event was extraordinary for various reasons. First of all, we welcomed 50 guests from all over the globe, the highest attendance since the start of the event in 2009.
This year’s edition was also an anniversary, since it was 25 years ago that Rob Havenaar and Mans Minekus started to develop the first prototype of an in vitro gastro intestinal model, soon to be known as TNO’s Intestine Model, TIM.
And we proudly introduced our new generation TIM system, which is designed as an easy-to-use, robustly engineered, smart and highly predictive in vitro model.
Last, but certainly not least, the program had a great line-up of reputable speakers from both academia and industry, presenting their latest results in both pharmaceutical and food in vitro gastro-intestinal research.
Both the setting and the informal atmosphere in which the event took place contributed to an open stimulating exchange of ideas, experiences and results. The new TIM model was received with great enthusiasm and the festive launch concluded a highly successful event.
All in all, we are proud to be part of the community of TIM Users and we invite you to join in.
For more information, please contact us: firstname.lastname@example.org.